Prevalence and Disability of vision impairment in Mexico: Evidence not seen or spoken about
Main Article Content
Abstract
According to the World Health Organisation, in 2015 about 253 million people, mainly from low- and middle-income countries, had vision impairment. Aim. We set out to provide an updated overview of the burden of visual impairment in Mexico to guide public health policy towards its prevention and control. Methods. Using data from the Global Burden of Disease study, we describe the age-standardised disability and prevalence rates (per 100,000 population) of total, severity, and cause-specific visual impairment and blindness with 95% uncertainty intervals (UIs) in Mexico from 1990 to 2019.
Results. During the study period, age-standardised prevalence of blindness and vision loss showed a national decrease of -7.0% from 10115.3 (95% UI 8540.6-11947.8) to 9410.2 (95% UI 7895.6-11230.4.1) cases per 100,000 population but it was not significant. Blindness prevalence showed a significant national decrease of -40.0% from 742.2 (95% UI 653.7-828.8) to 445.6 (95% UI 391.5-495.0) cases per 100,000 population. Decreasing trends in vision disability rates were not significant but changes were observable for blindness (-39.6%). Although a remarkable decline on disability rates due to glaucoma (-33.1%), cataract (-27.5%), and macular degeneration (-20.4%) was observed, neither was it significant.
Conclusions. The trends in prevalence of vision impairment and disability did not change significantly during the study period. Presbyopia and moderate vision loss accounted for most of the disability in all age groups. Inequalities between the poorest and richest states remained unchanged.
Keywords:
Burden of disease, blindness, vision impairment, YLDs
Article Details
How to Cite
JIMÉNEZ-CORONA, Aida et al.
Prevalence and Disability of vision impairment in Mexico: Evidence not seen or spoken about.
Medical Research Archives, [S.l.], v. 12, n. 7, july 2024.
ISSN 2375-1924.
Available at: <https://esmed.org/MRA/mra/article/view/5432>. Date accessed: 15 nov. 2024.
doi: https://doi.org/10.18103/mra.v12i7.5432.
Section
Research Articles
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
1. Bourne RR, Flaxman SR, Braithwaite T, et al. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(9):e888–e897. Doi:10.1016/S2214-109X(17)30293-0
2. Leasher JL, Braithwaite T, Furtado JM, et al. Prevalence and causes of vision loss in Latin America and the Caribbean in 2015: magnitude, temporal trends and projections. Br J Ophthalmol. 2019;103(7):885-893. Doi:10.1136/bjophthalmol-2017-311746
3. Campbell V, Crews J, Moriarty D, Zack M, DK; Blackman. Surveillance for sensory impairment, activity limitation, and health-related quality of life among older adults-United States, 1993-1997. Morb Mortal Wkly Rep. Published online 1999.
4. Lupsakko T, Mäntyjärvi M, Kautiainen H, Sulkava R. Combined hearing and visual impairment and depression in a population aged 75 years and older. Int J Geriatr Psychiatry. 2002;17(9):808-813. Doi:10.1002/gps.689
5. Kempen GI, Verbrugge LM, Merrill SS, Ormel J. The impact of multiple impairments on disability in community-dwelling older people. Age Ageing. 1998;27(5):595-604.
6. Schneider JM, Gopinath B, McMahon CM, Leeder SR, Mitchell P, Wang JJ. Dual sensory impairment in older age. J Aging Health. 2011;23(8):1309-1324. Doi:10.1177/0898264311408418
7. Manrique-Espinoza B, Salinas-Rodríguez A, Moreno-Tamayo KM, et al. Health conditions and functional status of older adults in Mexico. Salud Publica de Mex. 2013;55(Suppl 2):s323-s331.
8. Flaxman SR, Bourne RR, Resnikoff S, et al. Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis. Lancet Glob Health. 2017;5:e1221–34. Doi:10.1016/S2214-109X(17)30393-5
9. Madueña-Angulo SE, Beltran-Ontiveros SA, Leal-Leon E, et al. National sex- and age-specific burden of blindness and vision impairment by cause in Mexico in 2019: a secondary analysis of the Global Burden of Disease Study 2019. The Lancet Regional Health - Americas. 2023;24:100552. Doi:10.1016/j.lana.2023.100552
10. World Health Organization (WHO). Report of the 2030 Targets on Effective Coverage of Eye Care.; 2022.
11. Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020;396(10258):1204-1222. Doi:10.1016/S0140-6736(20)30925-9
12. Naghavi M, Abajobir AA, Abbafati C, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017;390(10100):1151-1210. Doi:10.1016/S0140-6736(17)32152-9
13. Allen C, Arora M, Barber RM, Bhutta Zulfiqar A, Brown Alexandria, Carter Austin. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545-1602. Doi:10.1016/S0140-6736(16)31678-6
14. Vos T, Abajobir AA, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017;390(10100):1211-1259. Doi:10.1016/S0140-6736(17)32154-2
15. Limburg H, Silva JC, Foster A. Cataract in Latin America: findings from nine recent surveys. Rev Panam Salud Publica. 2009;25(5):449-455. Doi:10.1590/s1020-49892009000500011
16. López-Star EM, Allison-Eckert K, Limburg H, Brea-Rodríguez I, Lansingh VC. Evaluación rápida de la ceguera evitable, incluida la retinopatía diabética, en Querétaro, México. Revista Mexicana de Oftalmología. 2018;92(2S):84-93. Doi:10.24875/RMO.M18000016
17. Lopez-Ramos A, Gomez-Bastar PA, Lansingh VC, et al. Rapid assessment of avoidable blindness: Prevalence of blindness, visual impairment and diabetes in nuevo leon, Mexico 2014. Ophthalmic Epidemiol. 2018;25(5-6):412-418. Doi:10.1080/09286586.2018.1501498
18. Polack S, Yorston D, López-Ramos A, et al. Rapid Assessment of Avoidable Blindness and diabetic retinopathy in Chiapas, Mexico. Ophthalmology. 2012;119(5):1033-1040. Doi:10.1016/j.ophtha.2011.11.002
19. National Institute of Public Health (Mexico) WHO (WHO). Mexico WHO Multi-Country Survey Study on Health and Health System Responsiveness 2000-2001.; 2014. Accessed April 29, 2024. https://apps.who.int/healthinfo/systems/surveydata/index.php/catalog/201/study-description
20. National Institute of Public Health (Mexico) WHO (WHO). Mexico WHO Study on Global AGEing and Adult Health 2009-2010.; 2011. http://ghdx.healthdata.org/record/mexico-who-study-global-ageing-and-adult-health-2009-2010
21. Pan American Health Organization (PAHO) University of Wisconsin-Madison, Inter-University Consortium for Political and Social Research (ICPSR), College of the Northern Border (COLEF), Research in Health and Demographics (INSAD), NATIONAL Institute of Med C for D and E. Mexico - Mexico City Survey on Health, Well-Being, and Aging in Latin America and the Caribbean 1999-2000. Ann Arbor, United States: Inter-University Consortium for Political and Social Research (ICPSR). Published online 2019.
22. Secretaría de Salud, Programa Sectorial de Salud. Programa de Acción Específico: Eliminación de Oncocercosis 2013-2018. Published online 2014:11-62. Accessed April 29, 2024. http://www.cndh.org.mx/sites/all/doc/Programas/VIH/OtrasPublicacionesdeinteresrelacionadosconelVIH/CENSIDA/CAUSES2016.pdf
23. Castanon Holguin AM, Congdon N, Patel N, et al. Factors associated with spectacle-wear compliance in school-aged Mexican children. Invest Ophthalmol Vis Sci. 2006;47(3):925-928. Doi:10.1167/iovs.05-0895
24. Ramírez-Sánchez EV, Arroyo-Yllanes ME, Magaña-García M. Determinación del estado refractivo en niños sanos, en el Hospital General de México. Rev Mex Oftalmol. 2003;77(3):120-123. https://www.medigraphic.com/pdfs/revmexoft/rmo-2003/rmo033e.pdf
25. Gomez-Salazar F, Campos-Romero A, Gomez-Campana H, et al. Refractive errors among children, adolescents and adults attending eye clinics in Mexico. Int J Ophthalmol. 2017;10(5):796-802. Doi:10.18240/ijo.2017.05.23
26. Baz Iglesias R, Solis Lopez S, Gaxiola Armenta M, Carrillo Gomez S, Baz Diaz Lombardo G. [Vision disorders in the municipality of Naucalpan]. Salud Publica Mex. 1984;26(1):17-25. http://dx.doi.org/
27. Villarreal GM, Ohlsson J, Cavazos H, Abrahamsson M, Mohamed JH. Prevalence of myopia among 12- to 13-year-old schoolchildren in northern Mexico. Optom Vis Sci. 2003;80(5):369-373. Doi:10.1097/00006324-200305000-00011
28. Pezzullo L, Cheung S, Tay-Teo K, Stevens B. El costo economico y carga de las enfermedades oculares y de la ceguera evitable en Mexico. Revista Mexicana de Oftalmologia. 2014;88(Supl 1):1-30.
29. Navarrete-López M, Puentes-Rosas E, Pineda-Pérez D, Martínez-Ojeda H. El papel del Fondo de Protección contra Gastos Catastróficos en la cobertura de atención a pacientes con cataratas. Salud Publica Mex. 2013;55(4):394-398. Doi:10.21149/spm.v55i4.7223
30. Trigos-Micoló I, Barquín-Donnadieu M, Gutiérrez-Soriano L. Programa Nacional de Cirugía Extramuros de la SSA 1994-2000. Cir Cir. 2019;69(4):160-166. https://www.medigraphic.com/pdfs/circir/cc-2001/cc014b.pdf
31. Trigos-Micoló I, Gutiérrez-Soriano L, Guzmán-López ME, Quintana-Pali L. Logros 2002-2003 del Programa Nacional de Cirugía Extramuros en la atención oftalmológica. Cir Cir. 2004;72(6):511-516.
32. Salud S de, ed. Secretaría de Salud, Comisión Nacional de Protección Social en Salud. Catálogo Universal de Servicios de Salud 2016. Published online 2016:28-777. https://www.cndh.org.mx/sites/all/doc/Programas/VIH/OtrasPublicacionesdeinteresrelacionadosconelVIH/CENSIDA/CAUSES2016.pdf
33. Executive Board 132. Draft action plan for the prevention of avoidable blindness and visual impairment 2014-2019: universal eye health: a global action plan 2014-2019: report by the Secretariat. Published online 2013. Doi:https://apps.who.int/iris/handle/10665/78620
34. Consejo Nacional para la Prevención y Tratamiento de Enfermedades Visuales (CNPTEV), Propuesta para la prevención de discapacidad visual y ceguera. Published online October 2014:1-66. Accessed April 29, 2024. https://www.gob.mx/salud/prensa/en-marcha-programa-nacional-para-la-prevencion-de-la-discapacidad-por-ceguera
2. Leasher JL, Braithwaite T, Furtado JM, et al. Prevalence and causes of vision loss in Latin America and the Caribbean in 2015: magnitude, temporal trends and projections. Br J Ophthalmol. 2019;103(7):885-893. Doi:10.1136/bjophthalmol-2017-311746
3. Campbell V, Crews J, Moriarty D, Zack M, DK; Blackman. Surveillance for sensory impairment, activity limitation, and health-related quality of life among older adults-United States, 1993-1997. Morb Mortal Wkly Rep. Published online 1999.
4. Lupsakko T, Mäntyjärvi M, Kautiainen H, Sulkava R. Combined hearing and visual impairment and depression in a population aged 75 years and older. Int J Geriatr Psychiatry. 2002;17(9):808-813. Doi:10.1002/gps.689
5. Kempen GI, Verbrugge LM, Merrill SS, Ormel J. The impact of multiple impairments on disability in community-dwelling older people. Age Ageing. 1998;27(5):595-604.
6. Schneider JM, Gopinath B, McMahon CM, Leeder SR, Mitchell P, Wang JJ. Dual sensory impairment in older age. J Aging Health. 2011;23(8):1309-1324. Doi:10.1177/0898264311408418
7. Manrique-Espinoza B, Salinas-Rodríguez A, Moreno-Tamayo KM, et al. Health conditions and functional status of older adults in Mexico. Salud Publica de Mex. 2013;55(Suppl 2):s323-s331.
8. Flaxman SR, Bourne RR, Resnikoff S, et al. Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis. Lancet Glob Health. 2017;5:e1221–34. Doi:10.1016/S2214-109X(17)30393-5
9. Madueña-Angulo SE, Beltran-Ontiveros SA, Leal-Leon E, et al. National sex- and age-specific burden of blindness and vision impairment by cause in Mexico in 2019: a secondary analysis of the Global Burden of Disease Study 2019. The Lancet Regional Health - Americas. 2023;24:100552. Doi:10.1016/j.lana.2023.100552
10. World Health Organization (WHO). Report of the 2030 Targets on Effective Coverage of Eye Care.; 2022.
11. Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020;396(10258):1204-1222. Doi:10.1016/S0140-6736(20)30925-9
12. Naghavi M, Abajobir AA, Abbafati C, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017;390(10100):1151-1210. Doi:10.1016/S0140-6736(17)32152-9
13. Allen C, Arora M, Barber RM, Bhutta Zulfiqar A, Brown Alexandria, Carter Austin. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545-1602. Doi:10.1016/S0140-6736(16)31678-6
14. Vos T, Abajobir AA, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017;390(10100):1211-1259. Doi:10.1016/S0140-6736(17)32154-2
15. Limburg H, Silva JC, Foster A. Cataract in Latin America: findings from nine recent surveys. Rev Panam Salud Publica. 2009;25(5):449-455. Doi:10.1590/s1020-49892009000500011
16. López-Star EM, Allison-Eckert K, Limburg H, Brea-Rodríguez I, Lansingh VC. Evaluación rápida de la ceguera evitable, incluida la retinopatía diabética, en Querétaro, México. Revista Mexicana de Oftalmología. 2018;92(2S):84-93. Doi:10.24875/RMO.M18000016
17. Lopez-Ramos A, Gomez-Bastar PA, Lansingh VC, et al. Rapid assessment of avoidable blindness: Prevalence of blindness, visual impairment and diabetes in nuevo leon, Mexico 2014. Ophthalmic Epidemiol. 2018;25(5-6):412-418. Doi:10.1080/09286586.2018.1501498
18. Polack S, Yorston D, López-Ramos A, et al. Rapid Assessment of Avoidable Blindness and diabetic retinopathy in Chiapas, Mexico. Ophthalmology. 2012;119(5):1033-1040. Doi:10.1016/j.ophtha.2011.11.002
19. National Institute of Public Health (Mexico) WHO (WHO). Mexico WHO Multi-Country Survey Study on Health and Health System Responsiveness 2000-2001.; 2014. Accessed April 29, 2024. https://apps.who.int/healthinfo/systems/surveydata/index.php/catalog/201/study-description
20. National Institute of Public Health (Mexico) WHO (WHO). Mexico WHO Study on Global AGEing and Adult Health 2009-2010.; 2011. http://ghdx.healthdata.org/record/mexico-who-study-global-ageing-and-adult-health-2009-2010
21. Pan American Health Organization (PAHO) University of Wisconsin-Madison, Inter-University Consortium for Political and Social Research (ICPSR), College of the Northern Border (COLEF), Research in Health and Demographics (INSAD), NATIONAL Institute of Med C for D and E. Mexico - Mexico City Survey on Health, Well-Being, and Aging in Latin America and the Caribbean 1999-2000. Ann Arbor, United States: Inter-University Consortium for Political and Social Research (ICPSR). Published online 2019.
22. Secretaría de Salud, Programa Sectorial de Salud. Programa de Acción Específico: Eliminación de Oncocercosis 2013-2018. Published online 2014:11-62. Accessed April 29, 2024. http://www.cndh.org.mx/sites/all/doc/Programas/VIH/OtrasPublicacionesdeinteresrelacionadosconelVIH/CENSIDA/CAUSES2016.pdf
23. Castanon Holguin AM, Congdon N, Patel N, et al. Factors associated with spectacle-wear compliance in school-aged Mexican children. Invest Ophthalmol Vis Sci. 2006;47(3):925-928. Doi:10.1167/iovs.05-0895
24. Ramírez-Sánchez EV, Arroyo-Yllanes ME, Magaña-García M. Determinación del estado refractivo en niños sanos, en el Hospital General de México. Rev Mex Oftalmol. 2003;77(3):120-123. https://www.medigraphic.com/pdfs/revmexoft/rmo-2003/rmo033e.pdf
25. Gomez-Salazar F, Campos-Romero A, Gomez-Campana H, et al. Refractive errors among children, adolescents and adults attending eye clinics in Mexico. Int J Ophthalmol. 2017;10(5):796-802. Doi:10.18240/ijo.2017.05.23
26. Baz Iglesias R, Solis Lopez S, Gaxiola Armenta M, Carrillo Gomez S, Baz Diaz Lombardo G. [Vision disorders in the municipality of Naucalpan]. Salud Publica Mex. 1984;26(1):17-25. http://dx.doi.org/
27. Villarreal GM, Ohlsson J, Cavazos H, Abrahamsson M, Mohamed JH. Prevalence of myopia among 12- to 13-year-old schoolchildren in northern Mexico. Optom Vis Sci. 2003;80(5):369-373. Doi:10.1097/00006324-200305000-00011
28. Pezzullo L, Cheung S, Tay-Teo K, Stevens B. El costo economico y carga de las enfermedades oculares y de la ceguera evitable en Mexico. Revista Mexicana de Oftalmologia. 2014;88(Supl 1):1-30.
29. Navarrete-López M, Puentes-Rosas E, Pineda-Pérez D, Martínez-Ojeda H. El papel del Fondo de Protección contra Gastos Catastróficos en la cobertura de atención a pacientes con cataratas. Salud Publica Mex. 2013;55(4):394-398. Doi:10.21149/spm.v55i4.7223
30. Trigos-Micoló I, Barquín-Donnadieu M, Gutiérrez-Soriano L. Programa Nacional de Cirugía Extramuros de la SSA 1994-2000. Cir Cir. 2019;69(4):160-166. https://www.medigraphic.com/pdfs/circir/cc-2001/cc014b.pdf
31. Trigos-Micoló I, Gutiérrez-Soriano L, Guzmán-López ME, Quintana-Pali L. Logros 2002-2003 del Programa Nacional de Cirugía Extramuros en la atención oftalmológica. Cir Cir. 2004;72(6):511-516.
32. Salud S de, ed. Secretaría de Salud, Comisión Nacional de Protección Social en Salud. Catálogo Universal de Servicios de Salud 2016. Published online 2016:28-777. https://www.cndh.org.mx/sites/all/doc/Programas/VIH/OtrasPublicacionesdeinteresrelacionadosconelVIH/CENSIDA/CAUSES2016.pdf
33. Executive Board 132. Draft action plan for the prevention of avoidable blindness and visual impairment 2014-2019: universal eye health: a global action plan 2014-2019: report by the Secretariat. Published online 2013. Doi:https://apps.who.int/iris/handle/10665/78620
34. Consejo Nacional para la Prevención y Tratamiento de Enfermedades Visuales (CNPTEV), Propuesta para la prevención de discapacidad visual y ceguera. Published online October 2014:1-66. Accessed April 29, 2024. https://www.gob.mx/salud/prensa/en-marcha-programa-nacional-para-la-prevencion-de-la-discapacidad-por-ceguera